Utilizing preclinical models, the research identifies chromatin landscape alterations driven by constitutive JAK2 activation, which enhance NF-κB signaling and chronic inflammation, a hallmark of MPN pathogenesis. Here, NFKB1 is linked to myeloproliferative disorder.